SGB-9768

DRUG3 trials

Sponsors

Suzhou Sanegene Bio Inc.

Conditions

C3 GlomerulopathyHealthy VolunteerIC-MPGNIgA Nephropathy (IgAN)PNH - Paroxysmal Nocturnal Hemoglobinuria

Phase 1

A Study of SGB-9768 in Adult Healthy Volunteers

CompletedNCT06501573

Suzhou Sanegene Bio Inc.Healthy Volunteer

Start: 2024-07-18End: 2026-05-07Updated: 2026-09-04

Phase 2

A Study of SGB-9768 in Patients With Complement-mediated Kidney Diseases

Active, not recruitingNCT06786338

Suzhou Sanegene Bio Inc.C3 Glomerulopathy, IC-MPGN, IgA Nephropathy (IgAN)

Start: 2025-06-06End: 2027-12-31Updated: 2026-09-04

Study of SGB-9768 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Not yet recruitingNCT07796256

Suzhou Sanegene Bio Inc.PNH - Paroxysmal Nocturnal Hemoglobinuria

Start: 2026-10-31End: 2027-12-31Target: 24Updated: 2026-09-04